2008
DOI: 10.1080/13813450802180882
|View full text |Cite
|
Sign up to set email alerts
|

Prostanoid function and cardiovascular disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0
4

Year Published

2009
2009
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(28 citation statements)
references
References 85 publications
0
24
0
4
Order By: Relevance
“…Accumulating evidences suggest that alterations in the production/release of prostanoids by the endothelium directly contribute to the endothelial dysfunction in vascular diseases (Yuhki et al, 2010;Iñiguez et al, 2008). In fact, the increased vasoconstriction and the reduced vasodilatation in MSG rats were corrected after COX inhibition.…”
Section: Discussionmentioning
confidence: 93%
“…Accumulating evidences suggest that alterations in the production/release of prostanoids by the endothelium directly contribute to the endothelial dysfunction in vascular diseases (Yuhki et al, 2010;Iñiguez et al, 2008). In fact, the increased vasoconstriction and the reduced vasodilatation in MSG rats were corrected after COX inhibition.…”
Section: Discussionmentioning
confidence: 93%
“…Prostacyclin (PGI 2 ) and thromboxane A 2 (TXA 2 ) are the two most important prostanoids modulating vascular thromboresistance [5]. PGI 2 is predominantly produced by endothelial cells and has potent anti-inflammatory, antiplatelet, anti-proliferative and vasodilatory effects [2].…”
Section: Introductionmentioning
confidence: 99%
“…In order to avoid platelet activation during the centrifugation processes, inhibitors of platelet function may be used (Prostacyclin PGI2 for example), with the potential drawback that these inhibitors may induce protein changes that will interfere with proteomics analysis. However, PGI2 has a short half-life and the changes in platelet physiology induced by PGI2 are usually reversible (Garcia et al, 2005a;Iñiguez et al, 2008). The quality and purity of the final platelet suspension should be evaluated.…”
Section: A Platelet Isolationmentioning
confidence: 99%